ライフサイエンスコーパス: mastoid

1 ses through the anterior (8.5-MHz probe) and mastoid (13-MHz probe) fontanelles.

2 onse rates were obtained with the B81 on the mastoid (83-92%), the lowest with the B81 on the forehea

3 diment in the paranasal sinuses and airways, mastoid air cell fluid, frothy fluid in the airways, pul

4 jects had fluid in the paranasal sinuses and mastoid air cells and had ground-glass opacity within th

5 mastoid; oVEMPs: to BCV with the B81 on the mastoid, BCV with the B81 on the forehead, and BCV with

6 ACS and BCV on the mastoid caused higher asymmetry compared to BCV forehead

7 Control subjects showed mastoid cell fluid (25%), sinus fluid (83%), subglottic

8 ultidetector CT findings of pan sinus fluid, mastoid cell fluid, subglottic tracheal and bronchial fl

9 ted pneumococcal isolates from middle ear or mastoid cultures from children from 2011 to 2013.

10 Passing current through mastoid electrodes (conventionally termed galvanic vesti

11 ACS and BCV with the B81on the mastoid evoked cVEMPs in 100% of ears.

12 r segment of the cochlear basal turn and the mastoid facial nerve (p = 0.040).

13 pler imaging with scans obtained through the mastoid fontanelle can depict CSVT at an early stage.

14 gs taken from electrodes near the ear (e.g., mastoid) in reference to a vertex electrode (Cz).

15 gnificantly (P = .0006) among the middle ear/mastoid isolates (2011, 50% [74/149]; 2012, 40.5% [47/11

16 the tympanic cavity (T); extension into the mastoid (M); and associated complications (C).

17 emur (nine), tibia (eight), mandible (five), mastoid (one), maxilla (one), zygomatic arch (one), rib

18 In all cases, unilateral mastoid opacification was observed.

19 bration (BCV) with the B81 transducer on the mastoid; oVEMPs: to BCV with the B81 on the mastoid, BCV

20 The B81 was feasible to elicit VEMPs with mastoid placement and can be used as an approved medical

21 , the featureless occipital region and small mastoid process are at variance with the large facial sk

22 s applied through electrodes placed over the mastoid process bilaterally.

23 CI, 42.0%-87.4%) for diseases of the ear and mastoid process to 96.8% (95% CI, 94.7%-98.8%) for neopl

24 t the stimulating anode was on the posterior mastoid process, stimulation caused standing subjects to

25 forward, square-wave stimuli applied to the mastoid processes evoked a polarity-specific T(z) respon

26 lar afferent responses to GVS applied to the mastoid processes of awake-behaving monkeys.

27 applied via vibrating elements placed on the mastoid processes were combined with the Locomotor Senso

28 vertical auditory porous, laterally bulbous mastoid processes, superiorly positioned posterior semic

29 s being more negative (relative to a average mastoid reference) than words encoded auditorily.

30 d for a surgery involving the atticus and/or mastoid region (OR, 4.8; 95% CI, 3.4-6.2).

31 40-min, 77.5 Hz, 15 mA, one forehead and two mastoid sessions of active or sham stimulation (n = 50 f

32 he stimulation on the frontal cortex and two mastoids significantly improved symptoms in first-episod

33 ponses similar in magnitude and direction to mastoid stimulation.

34 be established due to higher variability for mastoid stimulation.

35 Peering through the otic capsule bone during mastoid surgery, we imaged the lateral and posterior sem

36 With the head facing forward, unilateral mastoid vibration (500 Hz, 2 s, 136 dB force level) prod

37 nput while walking could be affected through mastoid vibration (MV) and changes are in the direction

38 igate how manipulating sensory input through mastoid vibration (MV) could affect dynamic postural con

39 ifferent direction characteristics than with mastoid vibration.

40 d through a montage of the forehead and both mastoids was safe and effective in intervening chronic i